BPC-157
Also known as Body Protection Compound
The flagship healing peptide for joints, tendons, and gut.
Emerging evidenceOverview
At a glance
Combining
Safety
Widely used; human trial data still limited.
Regulatory: On the FDA's restricted bulk-substance list; availability varies by pharmacy.
Not appropriate if: cancer-history.
Questions
What does BPC-157 do to help healing?⌄
It promotes angiogenesis (new blood vessel formation into injured tissue) and accelerates tissue repair across tendons, ligaments, muscle, and gut lining. It also helps reduce gut inflammation specifically.
How is it taken?⌄
Either by subcutaneous injection or orally. For injuries, SC injection near the affected area is preferred when possible. Oral delivery is more practical for gut applications. Dose range is 250 to 500 mcg, given 1 to 2 times daily.
How long is a typical cycle?⌄
4 to 8 weeks is the standard range, then reassessment.
Is BPC-157 FDA-approved?⌄
No. It is on the FDA's restricted bulk-substance list, which affects availability through compounding pharmacies. Access and source matter - your clinician will source it through appropriate channels.
Who should not use BPC-157?⌄
People with a cancer history should not use BPC-157. Its tissue-repair and angiogenesis-promoting properties present a theoretical concern in anyone with active or prior cancer.
What is the most common stack for recovery?⌄
BPC-157 and TB-500 together are the classic recovery combination - they target healing through overlapping but distinct mechanisms and are frequently used together for injury protocols.
Related protocols
Want a personalized protocol?
Exact dosing is set with a licensed provider in the PepDepo network. This page is education, not a prescription.
Book a consultEducation only, not medical advice. Peptides discussed are for informational purposes and many are not FDA-approved. Eligibility, prescribing, compounding, and dispensing are handled by appropriately licensed entities. Exact protocols and dosing are set with a licensed provider in the PepDepo network at consult. Content is pending clinical review.